Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

Bristol Myers Squibb CEO Christopher Boerner joins ‘Mad Money’ host Jim Cramer to talk its new schizophrenia treatment Cobenfy, its oncology business, and more.